Related Experiment Videos
A different perspective on breast cancer risk factors: some implications of the nonattributable risk
CA: a Cancer Journal for Clinicians
|September 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The consistency of combat exposure reporting and course of PTSD in Vietnam War veterans.
Journal of traumatic stress·2007
Mentholated cigarettes and smoking habits in whites and blacks.
Tobacco control·2002
Smoking and lung cancer risk in American and Japanese men: an international case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Early stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precision.
CA: a cancer journal for clinicians·2026
The new (version 9) American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging protocol for carcinoma of the vulva.
CA: a cancer journal for clinicians·2026
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries.
CA: a cancer journal for clinicians·2026
Serious mental illness and cancer: A call to action for equitable care.
CA: a cancer journal for clinicians·2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable.
CA: a cancer journal for clinicians·2026
Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.
CA: a cancer journal for clinicians·2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026